New drug combo shows promise for Tough-to-Treat liver cancer
Disease control
Not yet recruiting
This study tests a combination of two drugs, adebrelimab and apatinib, in people with advanced liver cancer that has worsened after previous treatment. The goal is to see if the combination can shrink tumors. About 47 adults will take part, receiving the drugs in 3-week cycles. T…
Phase: PHASE2 • Sponsor: Song Peng • Aim: Disease control
Last updated May 20, 2026 11:55 UTC